Evaluation of USP 3 Apparatus to Develop Biopredictive Fasted and Fed Dissolution Methods for Extended-Release Desvenlafaxine Succinate Tablets

Gelijkaardige items

• In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
  door: Marival Bermejo, et al.
  Gepubliceerd in: (2020-06-01)
• Quality Control Dissolution Data Is Biopredictive for a Modified Release Ropinirole Formulation: Virtual Experiment with the Use of Re-Developed and Verified PBPK Model
  door: Olha Shuklinova, et al.
  Gepubliceerd in: (2022-07-01)
• Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling
  door: Michele Georges Issa, et al.
  Gepubliceerd in: (2022-04-01)
• Evaluation of USP 3 Apparatus to Develop Biopredictive Fasted and Fed Dissolution Methods for Extended-Release Desvenlafaxine Succinate Tablets
  door: Gustavo V. Carapeto, et al.
  Gepubliceerd in: (2026-02-01)
• Using PBPK to Simulate Target Biopredictive Dissolution Profiles for Long‐Acting Injectables ‐ Where to Begin With Critical Bioavailability Attributes?
  door: Hannah Cleary, et al.
  Gepubliceerd in: (2026-03-01)